FLASH
Shkruar nga PamfletiHow Dorian Sadiku built an empire worth tens of millions of euros on bargains, family connections and a system that was captured from top to bottom. SPAK is late, but the track is open
Dorian Tahir Sadiku, one of the most powerful and controversial figures in the pharmaceutical industry in Albania, is now at the center of a multi-year scheme involving business, politics and extraordinary benefits from public funds. A foreign report obtained by Pamfleti defines him as a "profile of concern," but a detailed analysis of public facts and documented transactions shows that Sadiku's case is no longer a matter of risk, but a genuine matter of state capture.
Dorian Sadiku has built a career that at first glance seems like a success story. In 2006, he founded Delta Pharma with two partners. Only a year later, he formally stepped down from ownership, leaving all the shares to his partner, but without actually stepping down from the company's management. It was after this "step down" that the company signed its first major contract with a multinational company, confirming that Sadiku was still in full control.
From 2007 to today, Delta Pharma has become a regional power: with a presence in Kosovo, Bosnia and Herzegovina, with investments in logistics, automated warehouses and with a turnover that in 2022 reached over 4.5 billion lek. This growth does not come only from commercial capabilities, but from strong political ties that have begun to be documented especially since 2014.
That year, the Ministry of Health, led by Ilir Beqaj, now imprisoned for corruption, announced a major tender for reimbursable drugs. Initially, the tender required "Manufacturer Authorization", an essential criterion to guarantee quality and limit the intervention of intermediaries. After two weeks, this criterion was removed. This maneuver excluded international companies such as Roche and Pfizer, while favoring Delta Pharma, which distributed Novartis products.
Here comes a key element: DP MP Kliti Hoti , Novartis' representative for Albania, is the brother of Dorian Sadiku's wife. The family connection, the change in criteria and the final result of the tender are three links that directly connect Sadiku to the benefit from this process. This is the classic example of a conflict of interest with budgetary consequences. And while Beqaj is currently in prison for other affairs, this episode has not been officially included in the indictment against the main beneficiary; Dorian Sadiku.
After this moment, Sadiku continues to build a total vertical structure in the pharmaceutical sector. In 2015, he founded "Metro Farmaci" and in 2020 he bought 90% of the "Ditë e Natë" network, just five months after its creation. Within a year, he owns 100%. With this move, Sadiku's Delta Pharma imports and distributes the drugs, while Metro Farmaci sells them through its own network of pharmacies. This is not a free market. It is a monopoly built on connections and financed by the state budget.
In 2022, Sadiku created BONDES Holding , a company to manage his assets outside the pharmaceutical sector. A year later, he founded SADIKU INVESTMENTS , owned by family members. Both of these companies serve to shift capital and build a structure of protection against possible investigations.
In January 2023, the most suspicious financial move occurs: the creation of "Delta Holding" with a formal partner and then, on February 27, 2023, the sale of Delta Pharma for 903 million lek to this new company. Payment will be made over 10 years, from the profits that the company will generate; that is, without any real payment. This is a fictitious transaction, designed to hide ownership and prevent seizure by law enforcement agencies. Sadiku, who had left the company in 2007, returns as a co-owner with 50%, silently and covered by a legal scheme.
Throughout this time, Dorian Sadiku maintains a high public profile. As President of the Pharmaceutical Business Union, he organizes conferences, publishes opinions and positions himself as a reformer. But behind the scenes, he controls the drug network, creates barriers to competition and directly influences public decision-making. His companies have not been investigated for profits from tenders, nor for the changes to the criteria in 2014, nor for family conflicts of interest, nor for suspicious transactions in recent years.
SPAK has launched an investigation into this network. Contacts, joint trips and suspicious payments between Ilir Beqaj and people connected to Sadiku have been documented. But the ultimate beneficiary, who has built a structure that controls drugs, pharmacies and investments, has not yet been directly targeted.
This is no longer a sector issue. It is a system issue. Dorian Sadiku represents the purest model of economic power that uses political connections to build immunity from justice. And as long as he is not investigated as a direct beneficiary of the Beqaj affair, for the 2014 tender, for the exclusion of competitors, for fictitious transactions and for monopolistic control, justice in Albania will be truncated.
This is clear proof that politics and business, when they come together in silence, create oligarchs who are above the law. SPAK has the duty today not to be satisfied with formal names, but to go all the way to the real beneficiary. /Pamphlet
Lini një Përgjigje